Purpose
to support an independent preclinical efficacy study and continued analysis of a promising experimental HIV vaccine with significant potential to advance into human clinical testing
Grantee
Division
Global Health
Date
MARCH 2016
Region served
GLOBAL
Committed amount
$5,143,054
Grant topic
HIV
Duration (months)
30
Grantee location
New York, New York, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.